Delivery Order SPE2DR25D9239-SPE2DR26FFBW7

The Defense Logistics Agency awarded a delivery order valued at $70,298.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Perjeta (420 mg/14 mL vials). This firm fixed-price delivery order, issued on January 14, 2026, with an ultimate completion date of February 5, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The delivery will be performed at the awardee's Park Ridge facility.

This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to provide recurring pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. As an established prime vendor under this program, DMS Pharmaceutical Group has demonstrated substantial performance across a diverse portfolio of pharmaceutical products, including specialty oncology treatments, biologics, and medical consumables critical to military healthcare operations. The PPV-G GEN V contract, awarded in November 2025 with a ceiling value of $499,999,999 and completion date of December 31, 2036, positions the company as a key supplier within the federal pharmaceutical supply chain serving global DoD medical requirements.